Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Duprilot

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Intensive Care Medicine|December 21, 2017
Fatal meningococcemia mimicking intra-abdominal emergencyMadeleine Rousseaux, Marion Duprilot, Paer-Selim Abback, et al.
American Journal of Hematology|May 18, 2018
Exceptional microorganisms on blood smearMadeleine Rousseaux, Marion Duprilot, Frédérique Maire, et al.
The Journal of Antimicrobial Chemotherapy|January 26, 2017
Diversity and functionality of plasmid-borne VagCD toxin-antitoxin systems of Klebsiella pneumoniaeMarion Duprilot, Dominique Decre, Nathalie Genel, et al.
American Journal of Infection Control|February 28, 2016
Laboratory-based strategy using a new marketed polymerase chain reaction assay to manage diarrheic episodes among patients from rehabilitation and long-term care facilitiesMaud Salmona, Sarah Jolivet, Marion Duprilot, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2019
Emergence of the C1-M27 cluster in ST131 Escherichia coli from companion animals in FranceLuana C Melo, Marisa Haenni, Estelle Saras, et al.
Frontiers in Microbiology|June 20, 2019
Association Between Kinetics of Early Biofilm Formation and Clonal Lineage in <i>Escherichia coli</i>Saskia-Camille Flament-Simon, Marion Duprilot, Noémie Mayer, et al.
Scientific Reports|July 29, 2017
In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modificationSuzanne Bialek-Davenet, Noémie Mayer, Julia Vergalli, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 20, 2021
Temocillin as an alternative treatment for acute bacterial cholangitis: a retrospective microbiology susceptibility-based study of 140 episodesSylvain Chawki, Aurélien Sokal, Marion Duprilot, et al.
International Journal of Antimicrobial Agents|August 16, 2014
First case of multidrug-resistant blaNDM-1- and blaOXA-232-carrying Klebsiella pneumoniae and its probable cross-transmission in a French hospitalAurore Bousquet, Marion Duprilot, Didier Moissenet, et al.
Infection and Immunity|September 29, 2020
Success of Escherichia coli O25b:H4 Sequence Type 131 Clade C Associated with a Decrease in VirulenceMarion Duprilot, Alexandra Baron, François Blanquart, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Intensive Care Medicine|December 21, 2017
Fatal meningococcemia mimicking intra-abdominal emergencyMadeleine Rousseaux, Marion Duprilot, Paer-Selim Abback, et al.
American Journal of Hematology|May 18, 2018
Exceptional microorganisms on blood smearMadeleine Rousseaux, Marion Duprilot, Frédérique Maire, et al.
The Journal of Antimicrobial Chemotherapy|January 26, 2017
Diversity and functionality of plasmid-borne VagCD toxin-antitoxin systems of Klebsiella pneumoniaeMarion Duprilot, Dominique Decre, Nathalie Genel, et al.
American Journal of Infection Control|February 28, 2016
Laboratory-based strategy using a new marketed polymerase chain reaction assay to manage diarrheic episodes among patients from rehabilitation and long-term care facilitiesMaud Salmona, Sarah Jolivet, Marion Duprilot, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2019
Emergence of the C1-M27 cluster in ST131 Escherichia coli from companion animals in FranceLuana C Melo, Marisa Haenni, Estelle Saras, et al.
Frontiers in Microbiology|June 20, 2019
Association Between Kinetics of Early Biofilm Formation and Clonal Lineage in <i>Escherichia coli</i>Saskia-Camille Flament-Simon, Marion Duprilot, Noémie Mayer, et al.
Scientific Reports|July 29, 2017
In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modificationSuzanne Bialek-Davenet, Noémie Mayer, Julia Vergalli, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 20, 2021
Temocillin as an alternative treatment for acute bacterial cholangitis: a retrospective microbiology susceptibility-based study of 140 episodesSylvain Chawki, Aurélien Sokal, Marion Duprilot, et al.
International Journal of Antimicrobial Agents|August 16, 2014
First case of multidrug-resistant blaNDM-1- and blaOXA-232-carrying Klebsiella pneumoniae and its probable cross-transmission in a French hospitalAurore Bousquet, Marion Duprilot, Didier Moissenet, et al.
Infection and Immunity|September 29, 2020
Success of Escherichia coli O25b:H4 Sequence Type 131 Clade C Associated with a Decrease in VirulenceMarion Duprilot, Alexandra Baron, François Blanquart, et al.
Pageof 2